Cargando…

Dynamic Contrast-Enhanced MRI for Monitoring Antiangiogenic Treatment: Determination of Accurate and Reliable Perfusion Parameters in a Longitudinal Study of a Mouse Xenograft Model

OBJECTIVE: To determine the reliable perfusion parameters in dynamic contrast-enhanced MRI (DCE-MRI) for the monitoring antiangiogenic treatment in mice. MATERIALS AND METHODS: Mice, with U-118 MG tumor, were treated with either saline (n = 3) or antiangiogenic agent (sunitinib, n = 8). Before (day...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Youngkyu, Cho, Gyunggoo, Suh, Ji-Yeon, Lee, Chang Kyung, Kim, Young Ro, Kim, Yoon Jae, Kim, Jeong Kon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Radiology 2013
Materias:	Experimental and Others
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725353/ https://www.ncbi.nlm.nih.gov/pubmed/23901316 http://dx.doi.org/10.3348/kjr.2013.14.4.589

Ejemplares similares

Spatiotemporal heterogeneity of tumor vasculature during tumor growth and antiangiogenic treatment: MRI assessment using permeability and blood volume parameters
por: Kim, Cherry, et al.
Publicado: (2018)

Response of the Primary Auditory and Non-Auditory Cortices to Acoustic Stimulation: A Manganese-Enhanced MRI Study
por: Kim, Hyungjun, et al.
Publicado: (2014)

Early detection of antiangiogenic treatment responses in a mouse xenograft tumor model using quantitative perfusion MRI
por: Rajendran, Reshmi, et al.
Publicado: (2014)

Dynamic Contrast-Enhanced MRI Perfusion Parameters as Imaging Biomarkers of Angiogenesis
por: Kim, Sung Hun, et al.
Publicado: (2016)

Evaluation of Antiangiogenic Effects of a New Synthetic Candidate Drug KR-31831 on Xenografted Ovarian Carcinoma Using Dynamic Contrast Enhanced MRI
por: Yang, Jehoon, et al.
Publicado: (2011)

Increased Antiangiogenic Effect by Blocking CCL2-dependent Macrophages in a Rodent Glioblastoma Model: Correlation Study with Dynamic Susceptibility Contrast Perfusion MRI
por: Cho, Hye Rim, et al.
Publicado: (2019)

Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography
por: Zhu, Xiao-Dong, et al.
Publicado: (2011)

Multidisciplinary Functional MR Imaging for Prostate Cancer
por: Kim, Jeong Kon, et al.
Publicado: (2009)

Lack of Efficacy of Combined Antiangiogenic Therapies in Xenografted Human Melanoma
por: Adamcic, Una, et al.
Publicado: (2012)

Severe Portal Hypertension in Cirrhosis: Evaluation of Perfusion Parameters with Contrast-Enhanced Ultrasonography
por: Jeong, Woo Kyoung, et al.
Publicado: (2015)

Antitumor and Antiangiogenic Activities of Curcumin in Cervical Cancer Xenografts in Nude Mice
por: Yoysungnoen-Chintana, Pornphrom, et al.
Publicado: (2014)

Characteristics of quantitative perfusion parameters on dynamic contrast‐enhanced MRI in mammographically occult breast cancer
por: Ryu, Jung Kyu, et al.
Publicado: (2016)

Water-Exchange-Modified Kinetic Parameters from Dynamic Contrast-Enhanced MRI as Prognostic Biomarkers of Survival in Advanced Hepatocellular Carcinoma Treated with Antiangiogenic Monotherapy
por: Lee, Sang Ho, et al.
Publicado: (2015)

Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients
por: Ulyte, Agne, et al.
Publicado: (2016)

Leakage correction improves prognosis prediction of dynamic susceptibility contrast perfusion MRI in primary central nervous system lymphoma
por: Kim, Yeon Soo, et al.
Publicado: (2018)

Perfusable Vessel-on-a-Chip for Antiangiogenic Drug Screening with Coaxial Bioprinting
por: Gu, Zeming, et al.
Publicado: (2022)

Perfusion-Weighted MRI Parameters for Prediction of Early Progressive Infarction in Middle Cerebral Artery Occlusion
por: Kim, Hoon, et al.
Publicado: (2016)

Lumazine Synthase Protein Nanoparticle-Gd(III)-DOTA Conjugate as a T(1) contrast agent for high-field MRI
por: Song, YoungKyu, et al.
Publicado: (2015)

Influence of B(1)-Inhomogeneity on Pharmacokinetic Modeling of Dynamic Contrast-Enhanced MRI: A Simulation Study
por: Park, Bumwoo, et al.
Publicado: (2017)

(18)F-FDG PET Metabolic Parameters and MRI Perfusion and Diffusion Parameters in Hepatocellular Carcinoma: A Preliminary Study
por: Ahn, Sung Jun, et al.
Publicado: (2013)

Differentiation of pilocytic astrocytoma, medulloblastoma, and hemangioblastoma on diffusion-weighted and dynamic susceptibility contrast perfusion MRI
por: Kurokawa, Ryo, et al.
Publicado: (2022)

Transient perfusion in human melanoma xenografts.
por: Tufto, I., et al.
Publicado: (1995)

Accurate autocorrelation modeling substantially improves fMRI reliability
por: Olszowy, Wiktor, et al.
Publicado: (2019)

Fast lightweight accurate xenograft sorting
por: Zentgraf, Jens, et al.
Publicado: (2021)

Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy
por: Ebos, John ML, et al.
Publicado: (2014)

Reliability of dynamic susceptibility contrast perfusion metrics in pre- and post-treatment glioma
por: Kouwenberg, Valentina, et al.
Publicado: (2022)

The Neuromelanin-related T(2)* Contrast in Postmortem Human Substantia Nigra with 7T MRI
por: Lee, Jae-Hyeok, et al.
Publicado: (2016)

Dynamic contrast‐enhanced MRI of the patellar bone: How to quantify perfusion
por: Poot, Dirk H.J., et al.
Publicado: (2017)

Role of Dynamic Susceptibility Contrast Perfusion MRI in Glioma Progression Evaluation
por: Quan, Guanmin, et al.
Publicado: (2021)

Human placental perfusion measured using dynamic contrast enhancement MRI
por: Deloison, Benjamin, et al.
Publicado: (2021)

Quantification of pulmonary perfusion in idiopathic pulmonary fibrosis with first pass dynamic contrast-enhanced perfusion MRI
por: Weatherley, Nicholas D, et al.
Publicado: (2021)

Differentiation of angiogenic burden in human cancer xenografts using a perfusion-type optical contrast agent (SIDAG)
por: Wall, Alexander, et al.
Publicado: (2008)

Noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles
por: Cui, Yanfen, et al.
Publicado: (2016)

Monitoring Posterior Cerebral Perfusion Changes With Dynamic Susceptibility Contrast-Enhanced Perfusion MRI After Anterior Revascularization Surgery in Pediatric Moyamoya Disease
por: Seo, Yun Seok, et al.
Publicado: (2023)

Correlations of 3T DCE-MRI Quantitative Parameters with Microvessel Density in a Human-Colorectal-Cancer Xenograft Mouse Model
por: Ahn, Sung Jun, et al.
Publicado: (2011)

Pretreatment prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer: Perfusion metrics of dynamic contrast enhanced MRI
por: Lee, Jeongmin, et al.
Publicado: (2018)

Vascular biomarkers derived from dynamic contrast-enhanced MRI predict response of vestibular schwannoma to antiangiogenic therapy in type 2 neurofibromatosis
por: Li, Ka-Loh, et al.
Publicado: (2016)

Multiparametric Monitoring of Early Response to Antiangiogenic Therapy: A Sequential Perfusion CT and PET/CT Study in a Rabbit VX2 Tumor Model
por: Kim, Jung Im, et al.
Publicado: (2014)

Repeatability of Cerebral Perfusion Using Dynamic Susceptibility Contrast MRI in Glioblastoma Patients()()
por: Jafari-Khouzani, Kourosh, et al.
Publicado: (2015)

System identification theory in myocardial perfusion modeling of dynamic contrast-enhanced MRI
por: Vallée, Jean-Paul, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_jv94b3s1sk0rgpnol1jfnjvf6q